1 / 7

Antibody Production Market Trends, Investigation and Forecast 2020-2027

An extensive study of the product application and services conducted by subject matter experts assessing the market will help product owners to make a wise decision

samvi
Download Presentation

Antibody Production Market Trends, Investigation and Forecast 2020-2027

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antibody Production Market To Reach USD 26.16 Billion By 2026

  2. Market Summary Rising incidence of contagious diseases is a major factor influencing market growth. Market Size – USD 9.72 billion in 2018, Market Growth - CAGR of 13.1 %, Market Trends –Rise in targeted immunotherapy adoption, along with an increase in R&D investment of biotechnology and pharmaceutical companies.

  3. Our Approach Our Approach Market Summary The Antibody production market is expected to reach USD 26.16 Billion by 2026, according to a new report by Reports and Data. This can be mainly associated with the increasing prevalence of contagious diseases globally, coupled with the expanding demand for protein therapeutics, which is promoting the development of the global market. The clinical and commercial progress of monoclonal antibodies has resulted in the need for production of antibodies in mammalian cell culture on a large-scale. Based on statistics, the rise in targeted immunotherapy adoption along with enhanced acceptance by regulatory authorities for therapeutic antibodies and an increase in R&D investment of biotechnology and pharmaceutical companies stimulate the growth of the global market. Also, the rise in the prevalence of infectious diseases and growth in demand for protein therapeutics is expected to spur the market growth further. However , expensive primary antibodies will restrain the growth. Request for a sample of this research report @ https://www.reportsanddata.com/sample-enquiry-form/1404

  4. Our Approach Our Approach Market Summary Further key findings from the report suggest • The therapeutics are incredibly useful for treating cancer, rheumatoid arthritis, and other chronic diseases • The growing incidence of contagious diseases, coupled with expanding demand for protein therapeutics is expected to drive the growth of the market. • Other factors that are responsible for the growth of the market are raised R&D disbursement on biotechnology and pharmaceutical companies, the patent cessation of prosperous monoclonal antibodies, therapeutic antibodies by governing authorities, and acceptance of targeted immunotherapy. • The monoclonal class segment is estimated to reach USD 10.33 billion by 2026 at a CAGR of 13.2% during the forecast period. • Due to the growing demand in the treatment of chronic diseases including blood disorders, cancer, and growth hormone deficiency, this segment is expected to hold a significant share during the forecast period. • This downstream procedure includes the application of accurate, highly sophisticated, and effective products that include chromatography instruments & resins. To identify the key trends in the industry, click on the link below @ https://www.reportsanddata.com/report-detail/antibody-production-market

  5. Our Approach Our Approach Market Summary Key participants : Thermo Fisher Scientific, Inc., GeneTex, Inc., Eli Lilly and Company, Pall Corporation, Merck KGaA, Eppendorf AG, Cellab GmbH, Abcam PLC, and Sigma-Aldrich Corporation FiberCell Systems Inc., among others. For the purpose of this study, Reports and Data have segmented the global Antibody production market on the basis of Class, End-User, Process and Region: Class Outlook (Revenue, USD Million; 2016-2026) Monoclonal antibodies Murine Chimeric Humanized Polyclonal Antibodies End User Outlook (Revenue, USD Million; 2016-2026) Pharmaceutical & Biotechnology Companies Diagnostic Laboratories Research Institutes

  6. Our Approach Our Approach Market Summary Process Outlook (Revenue, USD Million; 2016-2026) Upstream Processing Downstream Processing Filtration Order Now @ https://www.reportsanddata.com/checkout-form/1404

  7. About Us Our Approach Our Approach About Us About Us Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com

More Related